Background-Heart function declines with age, but the genetic factors underlying such deterioration are largely unknown.
C ardiac disease and heart failure is the leading cause of death in industrialized countries. Aging is associated with many changes in the cardiovascular system, and it is a major risk factor for the development of cardiovascular disease and heart failure. Substantial improvements in life expectancy have led to a proportional increase in the population mostly at risk for heart disease, highlighting the need to understand the molecular mechanisms that contribute to age-related deterioration of cardiac function. In humans, the main age-related changes associated with cardiac insufficiency are reduced cardiac contractility and arrhythmias. [1] [2] [3] [4] 
Clinical Perspective on p 480
The wingless/Wnt (Wnt) signaling pathway plays critical roles in an array of biological processes, including maintenance of homeostasis in multiple tissues and regulation of stem cell proliferation. 5, 6 Interestingly, Wnt signaling seems to promote aging in mouse skeletal muscle stem cells but inhibits senescence in human fibroblasts. 7 Thus, it seems clear that a link exists between Wnt signaling and aging, but the specific molecular effectors have not been identified.
Canonical Wnt signaling is initiated when Wnt ligands bind frizzled/lipoprotein receptor protein receptors, which prevents degradation and promotes stabilization of cytosolic β-catenin/armadillo (β-cat), a key mediator of Wnt signaling. β-cat subsequently translocates to the nucleus, where it forms a complex with the DNA-binding protein T-cell specific, HMG-box (TCF)/pangolin (Pan) and other cofactors, enabling transcription of Wnt/TCF-responsive genes, such as Ubx in Drosophila. [8] [9] [10] The pygopus (pygo) gene encodes a transcriptional cofactor for canonical Wnt signaling in Drosophila, and pygo null mutations phenocopy the loss of Wnt signaling. [11] [12] [13] [14] In mammals, 2 pygo homologs, Pygo1 and Pygo2, have been identified: Pygo2 expression is ubiquitous, but Pygo1 is enriched in heart tissue, suggesting a possible cardiac-specific function. 15 Double Pygo1 and Pygo2 mutant mice do not exhibit obvious developmental heart defects, 16 but it is not known whether these molecules are required for adult heart function under stress conditions or during aging. Interestingly, studies of lens induction in mice have suggested that Pygo2 may have a Wnt-independent function. 17 In this study, we investigated the role of pygo in Drosophila heart model. We show that pygo is specifically expressed in adult myocardial cells and cardiac-specific knockdown of pygo drastically compromises heart function. In contrast to this strong pygo loss-of-function phenotype, knockdown of other canonical Wnt signaling components, such as β-cat and TCF, caused only mild defects in heart function. Furthermore, pygo mutants failed to show significant genetic interaction with other molecules involved in canonical Wnt signaling, including the TCF target gene Ubx and components of the Wnt signaling-associated mediator complex, skd and kto. We also show that in an isoproterenol (ISO)-induced cardiac hypertrophy model, Pygo1 protein itself is upregulated. Thus, we conclude that pygo function is critical for maintaining optimal adult heart performance and acts independently of canonical Wnt signaling, and increases in Pygo1 expression may mediate some of the effects of cardiac hypertrophy.
Methods
Semi-intact Drosophila hearts were prepared as described previously. 18, 19 Movies of beating hearts were recorded for 30 seconds with a high-speed EM-CCD camera (Hamamatsu) at 130 frames/s. Data were captured using HC Image software (Hamamatsu). Movies were analyzed with Semi-automatic Optical Heartbeat Analysis software to quantify heart periods, systolic and diastolic intervals, systolic and diastolic diameters, fractional shortening (FS), and arrhythmia indexes (defined as the SD of the heart period normalized to the median of each fly) and to produce M-mode records. 18, 20, 21 Immunohistochemistry was performed as previously described. 22 Cardiac hypertrophy was induced in male BALB mice (8-12 weeks of age) by continuous intraperitoneal injection of ISO (in 0.9% sodium 5 mg/kg per day) for 14 days as previously described. 23 Sham-operated animals were submitted to intraperitoneal injection of vehicle (0.9% sodium solution) for the same amount of time. Mice were kept for an additional 14 days after treatment and then were euthanized by cervical dislocation and hearts were surgically removed. The heart weight:body weight ratio was calculated, and hearts were then frozen in liquid nitrogen before real-time quantitative polymerase chain reaction or Western analysis, or fixed for immunohistochemistry (see Methods in the online-only Data Supplement).
Drosophila and mouse stocks and the methods for real-time quantitative polymerase chain reaction, Western blotting, and determination of lifespan are described in the Methods in the online-only Data Supplement.
Statistical Analysis
All statistical analyses were performed using Prism Statistical Software (Graph Pad, Inc, version 6). A 1-way ANOVA was used when comparing the effects of different genetic manipulations in flies of the same age. Data sets were tested for normal (Gaussian) distributions using the D'Agostino and Pearson omnibus normality test. For data sets that passed this test, we used a regular 1-way ANOVA followed by multiple comparisons post hoc tests (specific tests indicated in figure legends). Data sets that did not show a normal distribution were analyzed for significance using a Kruskal-Wallis test followed by a Dunn multiple comparison post hoc test. When analyzing heart function in flies with both differing genetic manipulations and differing ages, we used a 2-way ANOVA followed by a Tukey multiple comparisons post hoc test of significance. In all cases, P<0.05 were taken as significant. In all measures the pygo knockdown phenotype is more severe than that in response to arm/β-cat or TCF knockdown. Significance was determined using a 1-way ANOVA and Tukey multiple comparisons post hoc test (for normally distributed data: systolic interval, fractional shortening, and diameters) or Kruskal-Wallis with Dunn multiple comparisons test (for non-Gaussian data: heart period, diastolic interval, and arrhythmia index). Differences relative to the Hand4.2/+ control are indicated by individual asterisks; significance between experimental groups is indicated by the capped lines; *P<0.5, **P<0.01, and ***P<0.001. Sample size was 20 to 30 flies per genotype.
Results

pygo Is Expressed in the Adult Heart
Immunostaining of Drosophila adult hearts revealed that Pygo protein accumulates in the nuclei of cardiomyocytes but not in heart-associated pericardial cells ( Figure I in the onlineonly Data Supplement). We examined animals with heartspecific pygo knockdown acheived using RNA interference (RNAi) to inhibit gene expression; Pygo immunoreactivity in cardiomyocyte nuclei was reduced greatly or abolished, compared with the expression in wild-type hearts ( Figure IE -IH in the online-only Data Supplement). These results were corroborated by quantitative polymerase chain reaction, which showed that pygo mRNA expression in the pygo KD hearts was only 19% of the levels expressed in control hearts ( Figure  II 
pygo Is Required to Maintain Normal Heart Physiology
We characterized the effects of pygo loss of function on adult heart function using a semiautomated optical heartbeat analysis protocol. [18] [19] [20] Cardiac-specific pygo KD prolonged the heart period (ie, reduced heart rate) in 1-week-old flies ( Figure 1A ), and this was because of increases in both the systolic and diastolic intervals ( Figure 1B and 1C) . We also observed a significant increase in the incidence of arrhythmias (arrhythmia index) in pygo KD hearts compared with controls ( Figure 1D ). The cardiac phenotype induced by pygo KD is also illustrated in the M-mode traces obtained from high-speed movies, which show heart wall movements over time. 18, 19 M-Modes from pygo KD hearts exhibited long pauses between beats (asystoles), prolonged or multiple (fibrillatory) contractions, and wider systolic heart wall dimensions ( Figure 2A ).
Knockdown of pygo caused a dramatic reduction in cardiac contractility at young ages, as demonstrated by diminished FS, a classic measure of cardiac output ( Figure 1E ). The reduced FS was mainly attributable to systolic dysfunction because the diameters of pygo KD hearts during systole were markedly increased compared with the controls, whereas there was little effect on diastolic diameters ( Figure 3H ; see 1-week time point).
We confirmed these observations in an independent pygo KD line, which displayed a similar, albeit slightly less severe, phenotype ( Figure III in the online-only Data Supplement). Furthermore, transgenic overexpression of a wild-type pygo cDNA construct rescued the pygo KD phenotype; both systolic and diastolic intervals were significantly shortened in the hearts of pygo KD, pygo-overexpressing animals compared with the pygo KD hearts ( Figure 1B and 1C ). The decrease in FS was also rescued partially in these animals but not the increased arrhythmia index ( Figure 1D and 1E).
pygo Is Required for Normal Heart Morphology
The observed reduction in contractility suggested that cardiac structure might be altered in pygo KD hearts. Normal adult hearts contained densely packed, circumferentially organized myofibrils within the cardiomyocytes ( Figure 2B ). In contrast, all of the pygo KD hearts examined showed extensive myofibrillar disorganization and reorientation, as well as less densely packed myofibrils with obvious gaps (Figure 2B-2E; Figure IV in the online-only Data Supplement). These morphological defects were rescued partially by cardiac coexpression of the wild-type pygo transgene, with only 25% of hearts exhibiting myofibrillar defects ( Figure 2E ). Our observation that cardiac pygo overexpression itself in wild-type flies caused some mild structural heart defects (data not shown) may explain the inability of overexpression to rescue completely this pygo KD phenotype (Figures 1 and 2) . Overall, these data indicate that pygo expression in cardiomyocytes is required for the structural integrity and normal function of the heart. 
Cardiac pygo KD Causes an Accelerated Age-Dependent Deterioration of Heart Function
Several studies have shown that heart structure and function deteriorate with age in both flies and humans. 1, 21, [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] The average lifespan of different laboratory wild-type strains of Drosophila ranges between 40 and 80 days at 25 o C, suggesting that each week of age in a fly is equivalent to ≈1 decade in human age. In flies, cardiac senescence increases steadily after eclosion. 21, [33] [34] [35] Thus, in the current study, we examined the role of pygo in aging adult flies at 1, 3, and 5 weeks as representative of young, middle, and late middle ages, respectively, but prior to ages where significant mortality occurs (see also Figure VI in the online-only Data Supplement). We found that pygodepleted hearts exhibited dramatic age-associated changes in most of the cardiac parameters measured (Figure 3 ). The percentage of unusually long systolic intervals (>0.4 seconds, twice the average length in wild-type flies) 18, 20, 33 was markedly elevated in pygo KD flies compared with age-matched controls ( Figure 3E and Figure V in the online-only Data Supplement) and are reminiscent of the fibrillatory contractions observed in hearts from KCNQ mutant flies. 18 The percentage of unusually long diastolic intervals (>1 seconds) also increased with age in pygo KD hearts ( Figure 3F ). Unexpectedly, pygo KD caused a reduction in contractility (FS) in flies at 1 and 3 weeks but not at 5 weeks ( Figure 3G and 3H). This increase in contractility with age may be the result of increased calcium influx that would be expected to occur during the prolonged systolic intervals observed in older flies ( Figure 3B Examination of heart morphology in the pygo KD flies revealed an increase in the age-related disorganization of the normally compact myofibrillar structure of the myocardium (Figure 4) . Moreover, cardiac pygo KD decreased the median survival time of the flies by 24% ( Figure VI in the online-only Data Supplement). These data suggest that pygo plays a critical role in protecting the adult heart from age-related dysfunction, and that compromised heart function may significantly reduce the normal lifespan.
pygo Is Required in the Adult Heart to Maintain Its Function
To determine whether pygo is required for maintenance of cardiac performance in the adult fly, we disrupted pygo expression during the adult stage using the Gene Switch system 36 in conjunction with a hand-Gal4 driver (handGS-Gal4; see Materials and Methods). This driver is expressed specifically and conditionally in the heart on dietary supplementation with the antiprogestin compound, RU486. Hearts from RU486-fed flies exhibited increased heart periods, diastolic intervals, and arrhythmias, and reduced FS because of systolic dysfunction ( Figure VII in the online-only Data Supplement), which is similar to the phenotype of temporally unrestricted cardiac pygo KD animals ( Figure 1 ). These results indicate that pygo function is required specifically in the adult myocardium to prevent premature deterioration of heart function.
pygo Functions Independently of Canonical Wnt Signaling in the Adult Heart
pygo was identified originally as a critical component of canonical Wnt signaling that associates with β-Cat, BCL9/ Lgs, and TCF in the nucleus to activate transcription of Wnt-responsive genes. [11] [12] [13] [14] Therefore, we examined whether the heart-specific role of pygo was associated with canonical Wnt signaling. First, we determined the efficiency of RNAi KD of canonical Wnt signaling components using the established eye size assay. 13 In this assay, eye-specific expression of constitutively active β-cat/arm, GMR>arm*, causes a dramatic reduction in Drosophila eye size because of activation of Wg signaling ( Figure 5A ). Because this effect on the eye requires a functioning transcriptional complex that includes β-Cat/arm, Pygo, and TCF, we reasoned that this GMR>arm* model would allow us to gauge the relative extent of KD by each of our RNAi lines in vivo. We found that KD of TCF or β-cat/arm completely rescued the reduced eye phenotype induced by GMR>arm*, as shown by the normal eye size (Figure 5A , 5D, and 5E). In contrast, pygo KD was able to only partially suppress the GMR>arm* reduced eye phenotype ( Figure 5A and 5B) , and concomitant pygo overexpression almost completely reversed this partial rescue ( Figure 5A and 5C ). These findings demonstrate that the efficiency of pygo KD was less than that of the β-Cat/arm and TCF RNAi lines that we used.
Thus, if wnt signaling plays a role in the adult heart, then cardiac KD of TCF and β-cat/arm using these lines should affect heart function to a greater extent than pygo KD. Surprisingly, we found that cardiac-specific KD of β-cat/arm only modestly altered the cardiac parameters (Figure 1 , pink bars), and TCF KD had an even weaker effect (Figure 1 , blue bars). Therefore, disruption of β-cat/arm or TCF function had remarkably little effect on cardiac function compared with the striking pygo KD phenotype, which is in stark contrast to their relative potencies in the canonical Wnt signaling eye size assay ( Figure 5) .
In contrast to the weak effect of TCF KD, we found that a dominant-negative form of TCF (TCF-DN) induced a cardiac phenotype similar to that observed for β-cat/arm KD, with the exception that the reduction in FS was more pronounced (Figure 1, pink and purple bars) . It should be noted that DN constructs often induce stronger phenotypes than genetic loss of function. The weak effect of TCF KD on cardiac contractility contrasted with the strong effect of TCF DN suggests a gain-of-function phenotype.
This possibility is supported by the observation that TCF-DN hearts showed significant myofibrillar abnormalities, as previously observed, 37 compared with the β-cat/arm and TCF KD hearts, which contained few cardiomyocytes with myofibrillar abnormalities (Figure 2E ). However, the TCF-DN phenotype consisted mainly of a reorientation of myofibrils, which is quite different from the effects of pygo KD (Figure 2E ). Finally, an equally mild adult cardiac phenotype was observed on overexpression of activated GSK3β/shaggy (sgg), a negative regulator of Wnt signaling (data not shown). Taken together, these data indicate that canonical Wnt signaling does not play a major role in maintaining the structure and function of the adult heart, and thus it suggests that the cardiac role of pygo is largely independent of canonical Wnt signaling.
pygo Does Not Interact Genetically With β-Cat/TCF Complex Genes to Regulate Adult Heart Function
If pygo functions in a Wnt signaling-independent manner in the adult heart, we would predict that pygo mutants would not interact genetically with β-cat/arm or TCF/pangolin (pan) mutants with respect to heart function. To test this, we generated double-heterozygous combinations of pygo S123 with arm 2 or pan 3 . We found little difference in the function of the pygo S123 /arm 2 or pygo S123 /pan 3 hearts compared with control hearts ( Figure VIII in the online-only Data Supplement). These findings are consistent with our finding that the β-Cat/ TCF complex plays only a minor role in adult heart function and further support a canonical Wnt signaling-independent requirement for pygo in the adult heart.
To test this hypothesis further, we examined whether pygo genetically interacts with other components of the β-Cat/ TCF transcriptional complex or with the known TCF target gene, Ubx. Ubx is involved in cardiomyocyte reprogramming in the Drosophila heart during metamorphosis, and overexpression causes longitudinal reorientation of the normally circumferentially oriented myofibrils. 34 Interestingly, cardiac overexpression of pygo caused a similar myofibrillar reorientation (data not shown). Double-heterozygous pygo S123 /Ubx 9.22 animals showed only slight changes in cardiac parameters compared with the single heterozygotes ( Figure IX in the online-only Data Supplement). A similarly weak interaction was observed between pygo and kohtalo (kto) and skuld (skd), which encode that the mediator complex genes Med12 and Med13, that in the wing disk, are recruited by Pygo to regulate TCF-dependent transcription 38 (Figure IX in the online-only Data Supplement).
Finally, we tested whether the modest but significant heart phenotype observed with cardiac KD of β-cat/arm (Figure 1 ) could be enhanced in a pygo heterozygous background. Again, we observed no significant enhancement in cardiac dysfunction in hand4.2-Gal4/arm-RNAi; pygo S123 /+ hearts ( Figure 6 ), consistent with our hypothesis that pygo function in the adult heart occurs, in part, independently of the canonical Wnt pathway.
Genetic Interaction Between pygo and CaMKII in Regulating Heart Function
Because sustained, fibrillatory contractions, and impaired contractility are prominent defects in pygo KD hearts, we tested whether pygo interacts with genes involved in mediating intracellular calcium signaling. Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) is critical for mediating the effects of increased intracellular calcium in contracting cardiomyocytes and is a known modulator of contractility. 39 Although cardiac KD of CaMKII alone did not affect heart function, we found that CaMKII KD significantly increased heart dysfunction in the pygo KD flies (Figure 7 ). This genetic interaction suggests that pygo may function in conjunction with CaMKII to maintain adult heart performance. Figure 6 . Knockdown of β-cat/arm in a pygo heterozygous background. (A-E) Knockdown of β-cat/arm in a heterozygous pygo genetic background (hand4.2-Gal4/arm-RNAi; pygo S123 /+; showed no significant enhancement in cardiac dysfunction compared with that seen in response to cardiac-specific β-cat/arm knockdown alone. (F), There was a small increase in diastolic diameters in the pygo heterozygote background relative to β-cat/arm knockdown alone. Significance was determined using a 1-way ANOVA and Tukey multiple comparisons post hoc test. For non-Gaussian data (arrhythmia index), the Kruskal-Wallis with Dunn multiple comparisons test was used; significant differences among groups are indicated by capped lines; *P<0.5, **P<0.01, and ***P<0.001. Each bar represents 20 to 30 individual hearts that were analyzed for the indicated heart function parameters; data are displayed as mean±SEM.
Pygo1 Is Expressed in the Adult Heart and Is Upregulated in Response to Isoproterenol-Induced Cardiac Hypertrophy
We used Western blots to establish the embryonic and adult temporal expression pattern of Pygo1 in the mouse heart. Our results show that Pygo1 is relatively weakly expressed during embryonic stages, increases at birth, and is still present at significant levels in hearts from 6-week-old adults ( Figure XA in the online-only Data Supplement), consistent with previous findings that Pygo 1 is exclusively expressed in the adult mouse heart. 15 To determine whether Pygo1 levels are altered under pathological conditions, we used the ISO-induced hypertrophy mouse model. BALB mice were infused for 14 days with ISO, and 14 days later, animals were euthanized. Hearts from ISO-treated mice showed a 25% increase in the heart weight:body weight ratio compared with sham-treated controls ( Figure XB and XC in the online-only Data Supplement). Pygo1 mRNA expression was increased in ISO-infused mice as was expression of the cardiac hypertrophy marker atrial natriuretic factor compared with controls, suggesting that Pygo1 expression is upregulated during hypertrophy ( Figure XD in the online-only Data Supplement). Immunohistochemistry using α-Pygo1 antibody and Diaminobenzidine showed increased staining in transverse sections from ventricles of ISO-treated mice ( Figure 8A and 8B) , and Western blot analysis confirmed the increased protein levels of both Pygo1 and atrial natriuretic factor ( Figure 8C ) in hypertrophic hearts.
Discussion
The results described here provide strong evidence that pygo function is specifically required in the adult myocardium to maintain cardiac function and structural integrity and to counteract age-associated cardiac deterioration. The age-dependent changes in heart rhythm observed here, which are aggravated by pygo deficiency, are reminiscent of the increased incidence of atrial fibrillation in elderly humans. 1 It will be interesting to determine whether an age-related reduction in pygo function contributes to the development of arrhythmias in humans.
In contrast to the effects of pygo deficiency, we found that disruption of other Wnt pathway components, such as β-cat and TCF, had relatively mild effects on cardiac physiology and morphology. This was not because of inefficacy of the , Heart period was prolonged in cardiac-specific pygo knockdown because of (B) prolonged systolic and (C) diastolic intervals. CaMKII KD alone had no effect on HP but in conjunction with pygo knockdown caused an even greater increase in heart period and diastolic interval. (D), The incidence of arrhythmias was increased as expected in pygo knockdown but not in CaMKII knockdown hearts. The combined knockdown showed a trend toward further dysfunction in heart rhythm. (E), Fractional shortening decreased significantly in pygo diastolic intervals, but the double knockdown combination did not show a further decrease. (F), Interestingly, there was a significant increase in systolic diameter in pygo knockdown hearts that was exacerbated in the double knockdown. Hearts from double knockdown flies in diastole tended to be slightly dilated, but this was not different from the single CaMKII knockdown. For each genotype (bar) between 20 and 30 individual hearts were analyzed; data are displayed as mean±SEM. Significance was determined using a 1-way ANOVA and Tukey multiple comparisons post hoc test (for normally distributed data: systolic interval, fractional shortening, and diameters) or Kruskal-Wallis with Dunn multiple comparisons test (for non-Gaussian data: heart period, diastolic intervals, and arrhythmia index). Data that are significantly different from all 3 control lines (ie, Hand 4.2/+, CaMKII RNAi/+, and pygo-RNAi/+) are indicated by individual asterisks; significant differences between experimental groups are indicated by the capped lines; *P<0.5, **P<0.01, and ***P<0.001.
RNAi transgenes because β-cat/arm and TCF KD were more effective than pygo KD in curtailing Wnt signaling in the wellestablished eye size assay. Therefore, the critical role of pygo in cardiac maintenance is clearly independent of canonical Wnt signaling and the β-Cat/TCF complex. The genetic interaction with CaMKII suggests that pygo function may affect the intracellular calcium handling system in myocardial cells, but additional studies are required to address this question.
Expression of the TCF-DN construct, but not TCF KD, in the adult heart caused similar changes in heart function as pygo KD, in particular the reduction of FS ( Figure 1E ). Therefore, it is possible that Pygo might serve as an adaptor for a TCF-like transcription factor that binds to consensus TCF DNA-binding sites. In this scenario, TCF-DN (which retains DNA-binding ability) might interfere with the Wnt-independent function of pygo by occupying TCF consensus sites that normally do not bind wild-type TCF ( Figure XI in the online-only Data Supplement). Unfortunately, the fly heart does not provide sufficient material to perform chromatin immunoprecipitation or RNAseq experiments, which would be required to test this hypothesis.
Consistent with the results in the fly heart, we found that Pygo1 protein levels were significantly increased in response to ISO-induced hypertrophy along with the hypertrophy marker atrial natriuretic factor in the mouse model. These data indicate a role for Pygo1 in mammalian adult heart tissue and suggest that it is involved in the hypertrophic response to stress.
In summary, we propose a novel Wnt pathway-independent function for pygo in the adult Drosophila heart. The results described here provide strong evidence that pygo function is specifically required in the adult myocardium to maintain cardiac function and structural integrity and to counteract ageassociated cardiac deterioration. The fact that cardiac Pygo1 expression increases at birth in the mouse model 15 suggests that Pygo1 may play a similar maintenance function in vertebrates, and that increases in pygo1 expression may underlie cardiac hypertrophic responses. The age-dependent changes in heart rhythm observed here, which are aggravated by pygo deficiency, are reminiscent of the increased incidence of atrial fibrillation in elderly humans. 1 Because Pygo1 and Pygo2 are not obligatory for cardiogenesis in mammals, 16 it will be interesting to determine whether an age-related reduction in pygo function contributes to the development of arrhythmias in humans and whether they are critical for maintaining normal heart structure and function under stress conditions or during aging. 
